HCW Biologics (HCWB) Other Operating Expenses (2022 - 2025)

HCW Biologics (HCWB) has 4 years of Other Operating Expenses data on file, last reported at $13964.0 in Q4 2025.

• Quarterly Other Operating Expenses fell 59.63% year-over-year to $13964.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $68376.0 (down 21.4% YoY) and the FY2025 annual result came in at $68376.0, down 21.4% from the prior year.
• Other Operating Expenses advanced to $13964.0 in Q4 2025, from $13290.0 in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $383322.0 in Q1 2023 to a low of -$176397.0 in Q1 2022.
• A 4-year average of $91626.8 and a median of $25175.5 in 2024 frame the typical range for Other Operating Expenses.
• Annual changes were most pronounced in 2023 — Other Operating Expenses soared 58352.52% — and 2024, when it sank 95.18%.
• Tracing HCWB's Other Operating Expenses over 4 years: stood at $342972.0 in 2022, then sank by 74.86% to $86237.0 in 2023, then sank by 59.89% to $34593.0 in 2024, then tumbled by 59.63% to $13964.0 in 2025.
• The last three Other Operating Expenses figures came in at $13964.0 (Q4 2025), $13290.0 (Q3 2025), and $16373.0 (Q2 2025), per Business Quant data.